Ventyx Biosciences (NASDAQ:VTYX – Get Free Report) issued its quarterly earnings data on Tuesday. The company reported ($0.79) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.87) by $0.08, Briefing.com reports. During the same period in the prior year, the company earned ($0.62) earnings per share. Ventyx Biosciences Stock Performance Shares of […]
Ventyx Biosciences (NASDAQ:VTYX – Get Free Report) posted its quarterly earnings data on Tuesday. The company reported ($0.79) EPS for the quarter, beating analysts’ consensus estimates of ($0.87) by $0.08, Briefing.com reports. During the same period in the previous year, the firm earned ($0.62) earnings per share. Ventyx Biosciences Price Performance Shares of NASDAQ VTYX […]
Connor Clark & Lunn Investment Management Ltd. increased its holdings in Ventyx Biosciences, Inc. (NASDAQ:VTYX – Free Report) by 139.5% in the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 63,944 shares of the company’s stock after purchasing an additional 37,240 shares during the period. Connor Clark […]
Ventyx Biosciences (NASDAQ:VTYX – Get Free Report) posted its earnings results on Tuesday. The company reported ($0.79) EPS for the quarter, beating the consensus estimate of ($0.87) by $0.08, Briefing.com reports. During the same period last year, the firm earned ($0.62) earnings per share. Ventyx Biosciences Stock Up 27.6 % NASDAQ:VTYX traded up $1.67 during […]
Ventyx Biosciences (NASDAQ:VTYX – Get Free Report) issued its quarterly earnings data on Tuesday. The company reported ($0.79) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.87) by $0.08, Briefing.com reports. During the same quarter in the prior year, the business posted ($0.62) earnings per share. Ventyx Biosciences Stock Up 27.6 […]